Pregnancy Clinical Trial
Official title:
Investigation Into the Influence of Genetic Variation on Folate, Cobalamin and Related Metabolites
Verified date | December 10, 2007 |
Source | National Institutes of Health Clinical Center (CC) |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
This study will examine how the body metabolizes micronutrients, such vitamins, during
pregnancy and how genetic make-up influences their metabolism. Vitamin B12 and folate levels
in pregnancy have been linked to birth defects, such as neural tube defects, orofacial
clefts, and congenital heart disease. Other micronutrient levels may be related to other
birth defects or pregnancy complications. This study will characterize the patterns of
micronutrient status during pregnancy and compare it with genetic variants and biochemical
parameters. Information about the relationship between genes and vitamin metabolism may help
doctors advise women about their nutritional requirements during pregnancy to protect their
health and the health of their babies.
This study is a collaboration between NIH and Trinity College in Dublin, Ireland. Women of
Irish origin 18 years of age or older who are receiving prenatal care at the Coombe Women's
Hospital in Dublin may be enrolled. Fathers also may participate.
Upon entering the study, female participants complete a questionnaire relating to their food
and vitamin intake, alcohol consumption, smoking behavior, and use of medications, and
provide a blood sample. Additional blood samples are collected during routine clinic visits
at about 24 and 34 weeks of pregnancy, and again at delivery and from 6 weeks to 2 months
after the baby's birth. Permission will be requested to obtain a blood sample from the
umbilical cord at birth after it has been removed from the baby.
Fathers of the babies are also asked to answer a short questionnaire and to provide a DNA
sample for genetic studies. To collect the DNA, sterile cotton swabs are rubbed around the
inside of the mouth to obtain cheek cells from which the DNA is extracted.
Status | Completed |
Enrollment | 0 |
Est. completion date | December 10, 2007 |
Est. primary completion date | |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility | - Eligible participants will be women of Irish origin (older than 18) presenting for prenatal care to the Coombe Women's Hospital, Dublin, Republic of Ireland. Non-Irish women (a small proportion of the population) will be excluded because the prevalence of genetic polymorphisms can vary greatly among different populations; we already have an estimate of the distribution of this genotype in the Irish women. Members of the only minority group native to Ireland, the Travelers, will not be excluded. While culturally distinct, the Travelers are genetically similar to the majority population. Women with multiple pregnancy (more than one fetus) and users of IV drugs will be excluded. Women will be asked for permission to obtain a cord blood sample from the infant at delivery. Women will be asked to assist with recruitment of their partners (father of the fetus), who will be included if they consent. |
Country | Name | City | State |
---|---|---|---|
Ireland | The Coombe Maternity Hospital | Dublin |
Lead Sponsor | Collaborator |
---|---|
National Human Genome Research Institute (NHGRI) |
Ireland,
Kirke PN, Molloy AM, Daly LE, Burke H, Weir DG, Scott JM. Maternal plasma folate and vitamin B12 are independent risk factors for neural tube defects. Q J Med. 1993 Nov;86(11):703-8. — View Citation
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03442582 -
Afluria Pregnancy Registry
|
||
Terminated |
NCT02161861 -
Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study
|
N/A | |
Not yet recruiting |
NCT05934318 -
L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE)
|
N/A | |
Enrolling by invitation |
NCT05415371 -
Persistent Poverty Counties Pregnant Women With Medicaid
|
N/A | |
Completed |
NCT04548102 -
Effects of Fetal Movement Counting on Maternal and Fetal Outcome Among High Risk Pregnant Woman
|
N/A | |
Completed |
NCT03218956 -
Protein Requirement During Lactation
|
N/A | |
Completed |
NCT02191605 -
Computer-delivered Screening & Brief Intervention for Marijuana Use in Pregnancy
|
N/A | |
Completed |
NCT02223637 -
Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry
|
||
Recruiting |
NCT06049953 -
Maternal And Infant Antipsychotic Study
|
||
Completed |
NCT02577536 -
PregSource: Crowdsourcing to Understand Pregnancy
|
||
Not yet recruiting |
NCT06336434 -
CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT04786587 -
Alcohol Self-reporting During Pregnancy. AUTOQUEST Study.
|
||
Not yet recruiting |
NCT05412238 -
Formulation and Evaluation of the Efficacy of Macro- and Micronutrient Sachets on Pregnant Mothers and Children Aged 6-60 Months
|
N/A | |
Not yet recruiting |
NCT05028387 -
Telemedicine Medical Abortion Service Using the "No-test" Protocol in Ukraine and Uzbekistan.
|
||
Completed |
NCT02683005 -
Study of Hepatitis C Treatment During Pregnancy
|
Phase 1 | |
Completed |
NCT02783170 -
Safety and Immunogenicity of Simultaneous Tdap and IIV in Pregnant Women
|
Phase 4 | |
Recruiting |
NCT02507180 -
Safely Ruling Out Deep Vein Thrombosis in Pregnancy With the LEFt Clinical Decision Rule and D-Dimer
|
||
Recruiting |
NCT02619188 -
Nutritional Markers in Normal and Hyperemesis Pregnancies
|
N/A | |
Recruiting |
NCT02564250 -
Maternal Metabolism and Pregnancy Outcomes in Obese Pregnant Women
|
N/A | |
Completed |
NCT02379728 -
Ghana PrenaBelt Trial: A Positional Therapy Device to Reduce Still-Birth
|
N/A |